Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
Landgraf John C
   2. Issuer Name and Ticker or Trading Symbol
ABBOTT LABORATORIES [ABT] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Senior Vice President
(Last)
(First)
(Middle)
100 ABBOTT PARK ROAD		 3. Date of Earliest Transaction (Month/Day/Year)
03/16/2006
(Street)

ABBOTT PARK, IL 60064-6400		 4. If Amendment, Date Original Filed(Month/Day/Year)
 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		 7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common shares without par value 03/16/2006   G V 5,000 D $ 0 78,675 D  
Common shares without par value 12/06/2006   G V 290 D $ 0 78,385 D  
Common shares without par value 01/31/2007   M   16,667 A $ 39.26 95,052 D  
Common shares without par value 01/31/2007   M   21,281 A $ 41.0317 116,333 D  
Common shares without par value 01/31/2007   M   15,481 A $ 42.42 131,814 D  
Common shares without par value 01/31/2007   M   3,941 A $ 27.4328 135,755 D  
Common shares without par value 01/31/2007   M   2,875 A $ 34.7727 138,630 D  
Common shares without par value 01/31/2007   M   7,033 A $ 45.4723 145,663 D  
Common shares without par value 01/31/2007   S   7,033 D $ 53.04 138,630 D  
Common shares without par value 01/31/2007   F   48,689 D $ 53.19 89,941 D  
Common shares without par value               15,140 (1) I Profit Sharing Trust
Common shares without par value 03/16/2006   G V 5,000 A $ 0 25,000 (2) I Anne Marie Landgraf Living Trust
Common shares without par value               875 (3) (4) I By self for son

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		 6. Date Exercisable and Expiration Date
(Month/Day/Year)		 7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)		 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		 11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Option (right to buy) (5) $ 39.26 01/31/2007   M     16,667 08/03/2006 08/02/2014 common shares 16,667 $ 0 8,333 D  
Option (right to buy) (5) $ 41.0317 01/31/2007   M     21,281 02/20/2006 02/19/2014 common shares 21,281 $ 0 10,639 D  
Option (right to buy) (5) $ 42.42 01/31/2007   M     15,481 08/08/2006 02/13/2013 common shares 15,481 $ 0 5,621 D  
Option (right to buy) (5) $ 27.4328 01/31/2007   M     3,941 02/14/2000 02/13/2007 common shares 3,941 $ 0 0 D  
Option (right to buy) (5) $ 34.7727 01/31/2007   M     2,875 02/13/2001 02/12/2008 common shares 2,875 $ 0 0 D  
Option (right to buy) (5) $ 45.4723 01/31/2007   M     7,033 08/21/2001 02/13/2007 common shares 7,033 $ 0 0 D  
Option (right to buy) (5) $ 53.19 01/31/2007   A   13,588   08/01/2007 08/02/2014 common shares 13,588 $ 0 13,588 D  
Option (right to buy) (5) $ 53.19 01/31/2007   A   17,920   08/01/2007 02/19/2014 common shares 17,920 $ 0 17,920 D  
Option (right to buy) (5) $ 53.19 01/31/2007   A   13,270   08/01/2007 02/13/2013 common shares 13,270 $ 0 13,270 D  
Option (right to buy) (5) $ 53.19 01/31/2007   A   1,879   08/01/2007 02/12/2008 common shares 1,879 $ 0 1,879 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
Landgraf John C
100 ABBOTT PARK ROAD
ABBOTT PARK, IL 60064-6400		       Senior Vice President  

Signatures

 John A. Berry, by power of attorney for John C. Landgraf   02/02/2007
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Balance in the Abbott Laboratories Stock Retirement Trust as of February 01, 2007.
(2) Held in the Anne Marie Landgraf Living Trust. The reporting person and his spouse are co-trustees of the trust. The trust is revocable by his spouse.
(3) Includes shares acquired under the Abbott Laboratories Dividend Investment and Stock Purchase Plan in transactions exempt from Section 16(b) under Rule 16(a)-11.
(4) Reporting person disclaims beneficial ownership of all securities held by his son.
(5) Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.